Regulatory Database
A comprehensive database of drug regulations, guidelines, and standards in China.
-
ChinaIn forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaChinese Pharmacopoeia 9015 Guidelines for Studies and Quality Control of Drug Polymorphism9015 药品晶型研究及晶型质量控制指导原则In forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaIn forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaIn forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaIn forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaIn forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaIn forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaIn forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaIn forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
-
ChinaChinese Pharmacopoeia 9106 Guidelines for Pharmaceutical Evaluation Based on Microarrays9106 基于基因芯片的药物评价技术与方法指导原则In forceType: GuidelineRelease Date: 2020-07-02Implementation Date: 2020-12-30
Most Popular
- Chinese Pharmacopoeia 2020 Edition
- Chinese Pharmacopoeia 9012 Guidelines for Validation of Quantitative Analytical Method of Biological Samples
- Drug Administration Law of the People's Republic of China (2nd Revision)
- Provisions for Post-approval Changes of Drugs (Interim)
- Chinese Pharmacopoeia 9001 Guidelines for the Stability Testing of Drug Substances and Preparations